Jeong Oh

Title: Innovations by Jeong Oh in Treating Obesity and Liver Diseases

Introduction

Jeong Oh is an accomplished inventor based in Newbury Park, CA (US). He has made significant contributions to the field of medical treatments, particularly in addressing obesity and liver diseases. His innovative approach focuses on utilizing glucagon receptor antagonistic antibodies to combat these health issues.

Latest Patents

Jeong Oh holds a patent for "Methods for treating obesity and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis using glucagon receptor antagonistic antibodies." This patent outlines methods for treating or preventing obesity and nonalcoholic fatty liver diseases (NAFLDs) and nonalcoholic steatohepatitis (NASH) through the use of glucagon receptor blocking agents. The disclosure emphasizes the use of antigen-binding and antagonizing proteins, such as fully human antibodies, that specifically target and inhibit the function of the human glucagon receptor.

Career Highlights

Jeong Oh is currently associated with Remd Biotherapeutics, Inc., where he continues to develop innovative solutions for pressing health concerns. His work has garnered attention for its potential impact on public health, particularly in the management of obesity and liver diseases.

Collaborations

Jeong collaborates with notable colleagues, including Hai Yan and Jim Shi, who contribute to the research and development efforts at Remd Biotherapeutics, Inc. Their combined expertise enhances the potential for groundbreaking advancements in medical treatments.

Conclusion

Jeong Oh's innovative work in the field of medical treatments showcases his dedication to improving health outcomes for individuals suffering from obesity and liver diseases. His patent and ongoing research efforts position him as a key figure in the development of effective therapeutic strategies.